Efficacy and tolerability of ziprasidone in patients with treatment-resistant schizophrenia.

Authors
Category Primary study
JournalInternational clinical psychopharmacology
Year 2006
This multicentre, parallel-group study compared the efficacy and tolerability of ziprasidone and chlorpromazine in treatment-resistant schizophrenia (at least three treatment periods of at least 6 weeks each with two or more antipsychotic agents during the past 5 years without significant response) that was unresponsive to 6 weeks of open-label haloperidol (
Epistemonikos ID: deb741ca00f9924c6e0eea9e76acdb6024057d7a
First added on: Oct 11, 2014